Impact on Waist Circumference & Fat Distribution Research also shows that GLP-1 medications help reduce: Visceral fat (fat around the organs) Liver fat (in patients with fatty liver, NAFLD) Waist size and abdominal fat mass These improvements support cardiovascular health and metabolic stability, not just weight loss
Inadequate protein intake below 0.8 grams per kilogram of body weight per day accelerates muscle breakdown, which further reduces metabolic rate and deepens fatigue
First, PET and functional magnetic resonance imaging (fMRI) studies using visual, olfactory, and gustatory stimuli overwhelmingly find that perception of food and alcohol cues activates overlapping distributed neural networks
Troglitazone (TRO) , rosiglitazone (ROSI) and pioglitazone (PIO) were found to effectively and specifically inhibit ACSL4 (Kim et al., 2001), and TRO being TZD-protective due to its 6-chromophoranol structure ( ROSI showed better inhibition of ferroptosis ( thrombin inhibitors also inhibit ACLS4 and ferroptosis (Zhang et al., 2024a)
What it transports: Methylfolate (nature's preferred form) Folinic acid (therapeutic form) Folic acid (BLOCKS this pathway) Transport #2: Proton-Coupled Folate Transporter (PCFT) Supporting Route (10-20%) PCFT handles 10-20% of transport and becomes critical when FR is impaired